Pavaka Wound Care Participates in MHSRS 2026, the Military Health System Research Symposium
Updated: 7 days ago
August 3, 2026 — Pavaka Wound Care is participating in the 2026 Military Health System Research Symposium (MHSRS), held August 3–6. MHSRS is the Military Health System's annual scientific meeting for research that advances care for service members.
CEO and Co-Founder Brent Toto and Chief Medical Officer and Director of Military Affairs Robert J. O'Connell, MD, are representing the company. Throughout the week they are meeting with military medicine researchers, clinicians and industry partners, including at the Medical Technology Enterprise Consortium (MTEC) booth poster area.
MHSRS has been an important venue for the technology behind Pavaka's dressing. In August 2025, investigators from the Department of Defense–supported randomized study of the electroceutical dressing technology presented preliminary findings at the symposium. The full results are being prepared for peer-reviewed publication.
Pavaka's investigational dressing generates a low-level electric field at the wound surface. It is built on technology exclusively licensed from The Ohio State University and is being designed with military use in mind, including prolonged field care, where evacuation may be delayed and infection in traumatic wounds is a major risk.
Dr. O'Connell, a retired U.S. Army colonel and former Director of the Uniformed Services University's Infectious Disease Clinical Research Program, leads Pavaka's engagement with the military health community. Conversations at MHSRS help the company understand military requirements, identify research collaborators and plan the evidence it will need to serve service members.
Pavaka thanks MTEC and the MHSRS organizers for convening this community each year.
Readers interested in Pavaka's military health work can contact the company through www.pavakawoundcare.com.
Pavaka's presence at MHSRS also builds on its outreach earlier in 2026. That included exhibiting at OPMED 2026 in San Antonio in March and pitching as a Wound Shark finalist at the Wound Healing Society Annual Meeting in April.
"MHSRS is where military medicine sets its research agenda. Being in the room, listening and building relationships is how we make sure Pavaka is solving the problems military clinicians actually face." — Brent Toto, CEO and Co-Founder
Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.
About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.


Comments